Immunogenicity and Safety of V70P5 Revaccination Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

December 31, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

Adjuvanted seasonal influenza vaccine

Full or half dose of adjuvanted seasonal influenza vaccine; Full or half dose of unadjuvanted seasonal influenza vaccine

Trial Locations (16)

70211

Kuopio Vaccine Research Clinic, Microkatu 1, N-building, 2nd floor, PL 1188, Kuopio

FI-33520

University of Tampere Medical School, Vaccine Research Center / Tampere yliopisto rokotetutkimuskeskus, Biokatu 10, Tampere

FI-00100

Helsinki South, Vaccine Research Clinic, Vuorikatu 18, 3 floor, Helsinki

FI-00930

Helsinki East, Vaccine Research Clinic, Itäkeskuksen kauppakeskus/Agenttitalo, Turunlinnantie 8, 4.floor, Helsinki

FI-04400

Järvenpää, Vaccine Research Clinic, Yhteiskouluntie 17, Järvenpää

FI-67100

Kokkola Vaccine Research Clinic, Rantakatu 7, Kokkola

FI-48600

Kotka Vaccine Research Clinic, Karjalantie 10-12, Kotka

FI-15140

Lahti Vaccine Research Clinic, Vesijärvenkatu 74, Lahti

FI-90220

Oulu Vaccine Research Clinic, Kiviharjunlenkki 6, Oulu

FI-28100

Pori Vaccine Research Clinic, Yrjönkatu 23 (4th floor), Pori

FI-60100

Seinäjoki Vaccine Research Clinic, Keskuskatu 6, Seinäjoki

FI-33100

Tampere Vaccine Research Clinic, Pinninkatu 47 (1. floor), Tampere

FI-02100

Espoo Vaccine Research Clinic, Länsituulentie 10, 4th floor, Tapiontori 1, Espoo

FI-20520

Turku Vaccine Research Clinic, Lemminkäisenkatu 14-18 B (4th floor), Turku

FI-01300

Vantaa East, Vaccine Research Clinic, Asematie 11 a 16, Vantaa

FI-01600

Vantaa West, Vaccine Research Clinic, Jönsaksentie 6 B, 3rd floor, Vantaa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY